Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis-Reference-Cited by-同舟云学术

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

Published:2011-04-22 Issue:5 Volume:13 Page:723-746
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:Europace

Author:

Lip G. Y. H.,Andreotti F.,Fauchier L.,Huber K.,Hylek E.,Knight E.,Lane D. A.,Levi M.,Marin F.,Palareti G.,Kirchhof P.,Collet J.-P.,Rubboli A.,Poli D.,Camm J.,

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/13/5/723/7535320/eur126.pdf

Reference178 articles.

1. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA)

2. Guidelines for the management of atrial fibrillation

3. Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

4. New oral anticoagulant drugs in cardiovascular disease

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study;Cardiology and Therapy;2024-08-03

2. The 2023 WSES guidelines on the management of trauma in elderly and frail patients;World Journal of Emergency Surgery;2024-05-31

3. Unraveling the Paradox: Can Anticoagulation Improve Outcomes in Patients With Heart Failure and Increased Bleeding Risk?;Cureus;2024-04-03

4. Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study;Cardiology and Therapy;2024-02-06

5. Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program;Clinical and Applied Thrombosis/Hemostasis;2024-01